These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 3621278)

  • 1. Methodology for clinical trials with antiarrhythmic drugs to prevent cardiac death: US experience.
    Bigger JT
    Cardiology; 1987; 74 Suppl 2():40-56. PubMed ID: 3621278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can antiarrhythmic drugs survive survival trials?
    Pratt CM; Waldo AL; Camm AJ
    Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why patients with congestive heart failure die: arrhythmias and sudden cardiac death.
    Bigger JT
    Circulation; 1987 May; 75(5 Pt 2):IV28-35. PubMed ID: 3552300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?].
    Zrenner B; Koller B; Rudolph W
    Herz; 1990 Apr; 15(2):90-102. PubMed ID: 2188895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When is drug therapy warranted to prevent sudden cardiac death?
    Singh BN
    Drugs; 1991; 41 Suppl 2():24-46. PubMed ID: 1711967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists?
    Stevenson WG; Ridker PM
    JAMA; 1996 Aug; 276(6):481-5. PubMed ID: 8691557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium.
    Lucchesi BR
    Am J Cardiol; 1984 Jul; 54(2):14A-19A. PubMed ID: 6380259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with malignant or potentially malignant ventricular arrhythmias: opportunities and limitations of drug therapy in prevention of sudden death.
    Bigger JT
    J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):23B-26B. PubMed ID: 3889110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New aspects of the clinical use of anti-arrhythmia agents with special reference to acute therapy of ventricular tachycardia (lidocaine vs. ajmaline)].
    Manz M; Mletzko R; Jung W; Lüderitz B
    Herz; 1990 Apr; 15(2):79-89. PubMed ID: 2188894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Are anti-arrhythmia agents superior to a beta blocker in treating life-threatening ventricular arrhythmias? Preliminary results of a controlled study].
    Steinbeck G; Andresen D; von Leitner ER
    Z Kardiol; 1986; 75 Suppl 5():47-55. PubMed ID: 2435071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of advancing age on the efficacy and side effects of antiarrhythmic drugs in post-myocardial infarction patients with ventricular arrhythmias. The CAST Investigators.
    Akiyama T; Pawitan Y; Campbell WB; Papa L; Barker AH; Rubbert P; Friedman L; Keller M; Josephson RA
    J Am Geriatr Soc; 1992 Jul; 40(7):666-72. PubMed ID: 1607582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What is the latest in anti-arrhythmia therapy?].
    Gloor HO
    Schweiz Med Wochenschr; 1991 Nov; 121(47):1711-4. PubMed ID: 1720259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The azimilide post-infarct survival evaluation (ALIVE) trial.
    Camm AJ; Karam R; Pratt CM
    Am J Cardiol; 1998 Mar; 81(6A):35D-39D. PubMed ID: 9537221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular arrhythmias.
    Kavanagh KM; Wyse DG
    CMAJ; 1988 May; 138(10):903-13. PubMed ID: 3284626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction].
    Arós Borau F; Loma-Osorio A; Torres Bosco A
    Rev Esp Cardiol; 1996 Mar; 49(3):157-65. PubMed ID: 8685518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reassessment of benefit-risk ratio and treatment algorithms for antiarrhythmic drug therapy after the cardiac arrhythmia suppression trial.
    Anderson JL
    J Clin Pharmacol; 1990 Nov; 30(11):981-9. PubMed ID: 2122984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of ventricular arrhythmias in relation to sudden cardiac death: therapeutic implications.
    Surawicz B
    J Am Coll Cardiol; 1987 Aug; 10(2):435-47. PubMed ID: 3298363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the definition and meaning of proarrhythmia during initiation of antiarrhythmic drug therapy from the Cardiac Arrhythmia Suppression Trial and its pilot study. The CAST and CAPS Investigators.
    Wyse DG; Morganroth J; Ledingham R; Denes P; Hallstrom A; Mitchell LB; Epstein AE; Woosley RL; Capone R
    J Am Coll Cardiol; 1994 Apr; 23(5):1130-40. PubMed ID: 8144779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.